Referências
130
163 - Nguyen M, Dougados M, Berdah L, Amor B. Diacerhein in the treatment of
osteoarthritis of the hip. Arthritis Rheum. 1994;37(4):529-36.
164 - Louthrenoo W, Nilganuwong S, Aksaranugraha S, Asavatanabodee P,
Saengnipanthkul S, Thai Study Group. The efficacy and safety of diacerein in
the treatment of painful osteoarthritis of the knee. A randomized, multicentre,
doubleblind, piroxicam-controlled, parallel-group, phase III study. In: 11° Asia
Pacific League of Associations for Rheumatology Congress, Jeju Island,
Korea, 11 –15 sep. 2004.
165 - Tang F L, Wu DH, Lu ZG, Huang F, Zhou YX. The efficacy and safety of
diacerein in treatment of painful osteoarthritis of the knee. In: 11° Asia Pacific
League of Associations for Rheumatology Congress, Jeju Island, Korea, 11 –
15 sep. 2004.
166 - Dougados M, Nguyen M, Berdah L, Mazieres B, Vignon E, Lequesne M;
ECHODIAH Investigators Study Group. Evaluation of the structure-modifying
effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-
controlled trial. Evaluation of the chondromodulating effect of diacerein in OA
of the hip. Arthritis Rheum. 2001;44(11):2539-47. Comment in: Clin Exp
Rheumatol. 2003;21(2):152-4.
167 - Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, Altman R,
Brandt K, Dougados M, Lequesne M. Recommendations for a core set of
outcome measures for future phase III clinical trials in knee, hip, and hand
osteoarthritis. Consensus development at OMERACT III. J Rheumatol.
1997;24(4):799-802.
168 - Pham T, Van Der Heijde D, Lassere M, Altman RD, Anderson JJ, Bellamy N,
Hochberg M, Simon L, Strand V, Woodworth T, Dougados M; OMERACT-
OARSI. Outcome variables for osteoarthritis clinical trials: The OMERACT-
OARSI set of responder criteria. J Rheumatol. 2003;30(7):1648-54.
169 - Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and
validity of the visual analogue scale. Pain. 1983;16(1):87-101.